APA (7th ed.) Citation

FS, H., Z, S., & H, K. (2025). Is Including a Carbapenem in Treatment Regimens for Infections Caused by Multidrug-Resistant Gram-Negative Pathogens Still Reasonable? American journal of therapeutics. https://doi.org/10.1097/MJT.0000000000001980

Chicago Style (17th ed.) Citation

FS, Hosseini, Sharifi Z, and Khalili H. "Is Including a Carbapenem in Treatment Regimens for Infections Caused by Multidrug-Resistant Gram-Negative Pathogens Still Reasonable?" American Journal of Therapeutics 2025. https://doi.org/10.1097/MJT.0000000000001980.

MLA (9th ed.) Citation

FS, Hosseini, et al. "Is Including a Carbapenem in Treatment Regimens for Infections Caused by Multidrug-Resistant Gram-Negative Pathogens Still Reasonable?" American Journal of Therapeutics, 2025, https://doi.org/10.1097/MJT.0000000000001980.